Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 7, 2006; 12(29): 4721-4726
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4721
CCR5Δ32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C
Ankur Goyal, PV Suneetha, GT Kumar, Deepak K Shukla, Naveen Arora, Shiv K Sarin
Ankur Goyal, Department of Gastroenterology, G.B. Pant Hospital, New Delhi, Institute of Genomic and Integrative Biology, (Formerly CBT), Mall Road, Delhi, Dr. Ambedkar Center for Biomedical Research, University of Delhi, India
PV Suneetha, GT Kumar, Shiv K Sarin, Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India
Deepak K Shukla, Division of Non-communicable Disease, Indian Council of Medical Research, Ansari Nagar, New Delhi, India
Naveen Arora, Institute of Genomic and Integrative Biology, (Formerly CBT), Mall Road, Delhi, India
Supported by National Task Force Project from the Indian Council of Medical Research; supported by Council of Scientific and Industrial Research (CSIR), New Delhi to Ankur Goyal, a Senior Research Fellow
Correspondence to: Dr. SK Sarin, MD, DM, FNA, Director, Professor and Head, Department of Gastroenterology, G.B. Pant Hospital, University of Delhi, New Delhi-110002 and Adjunct Professor, Molecular Medicine, Jawaharlal Lal Nehru University, New Delhi, India. sksarin@nda.vsnl.net.in
Telephone: +91-11-23232013 Fax: +91-11-23219710
Received: August 17, 2005
Revised: August 28, 2005
Accepted: October 10, 2005
Published online: August 7, 2006
Core Tip